Summer Special! Get NewsNow Essentials at just £3.49 a month (12% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £3.49 a month (12% OFF!). Subscribe and saveSummer Special! Upgrade here at £3.49/m (12% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Teva
Pharmaceuticals
AstraZeneca
Novartis
Johnson and Johnson
Eli Lilly
GSK
Bristol Myers Squibb
Pfizer
Sanofi
Topics

Advertisement

Teva

Share

Top Latest Popular

🧊 FINALLY, SOMETHING COOL! £3.49 a month for NewsNow Essentials. Upgrade here

🧊 FINALLY, SOMETHING COOL! NewsNow Essentials at just £3.49 a month. Faster, slicker & ad free. Upgrade here

Branded drugs boost Teva revenue Globes 6d

Globes 6d

Wall Street Pharma

Teva’s $40 billion comeback brings Wall Street’s biggest prize into view CTech 5d

CTech 5d

Wall Street S&P 500

Stock Markets (World)

Dear Teva pharmaceutical stock fans, mark your calendars for September 14 Barchart 2d

Barchart 2d

Stock Markets (World) Stock Market

Advertisement

Advertisement

Deckers sales rise as Hoka and international markets drive growth The Industry London 13:09 Fri, 24 Jul

The Industry London 13:09 Fri, 24 Jul

Composition or Method? How amgen and Teva are reshaping drug patent strategy JD Supra 17:11 Wed, 22 Jul

JD Supra 17:11 Wed, 22 Jul

Eli Lilly Patent Law

Intellectual Property

Other barks & bites for Friday, July 17: CJEU says commercial partnership may make Google liable for gambling ads; cafc corrects cfc on book of wisdom; tillis indicates pera tweaks IPWatchdog.com 20:48 Fri, 17 Jul

IPWatchdog.com 20:48 Fri, 17 Jul

Thom Tillis North Carolina Senate

Advertisement

Advertisement

Latest

Yesterday

Teva Beats UnitedHealth’s RICO Claim for Copaxone Charity Copays Bloomberg Law 16:03 Mon, 03 Aug

Sunday

Why Teva Pharmaceutical Stock Surged This Week The Motley Fool 17:53 Sun, 02 Aug

Dear Teva Pharmaceutical Stock Fans, Mark Your Calendars for September 14 Barchart 15:18 Sun, 02 Aug

Thursday

Teva Q2 Earnings Lag Estimates, 2026 Revenue View Raised, Stock Rises Zacks 18:31 Thu, 30 Jul

Teva’s $40 billion comeback brings Wall Street’s biggest prize into view CTech 10:45 Thu, 30 Jul

Wednesday

Teva's Innovative Drug Portfolio Fuels Growth as Company Raises Outlook, Transitions to Direct NYSE Listing Benzinga 19:04 Wed, 29 Jul

Branded drugs boost Teva revenue Globes 13:15 Wed, 29 Jul

Teva Pharmaceutical Slips To Loss In Q2, Raises FY26 Revenue Outlook; Stock Up In Pre-Market RTT News 12:49 Wed, 29 Jul

Uzedy®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook Business Wire (Press Release) 12:46 Wed, 29 Jul

Teva posts strong revenue growth as branded drugs surpass $1 billion, despite acquisition-driven loss CTech 12:43 Wed, 29 Jul

Advertisement

Advertisement

Advertisement

Teva News

NewsNow brings you the latest news from the world’s most trusted sources on Teva. NewsNow aims to be the world’s most accurate and comprehensive Teva news aggregator, bringing you the latest headlines automatically and continuously 24/7.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Industry Sectors Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis